Hints and tips:
Related Special Reports
...Monday’s acquisition by Novartis of Seattle-based biotech firm Chinook Therapeutics for up to $3.5bn is a case in point....
...The company has already delivered AI-designed molecules for infectious disease vaccines to a large pharmaceutical company....
...However, the road there will continue to be a bumpy one,” said Rouse....
...But more than this, I totally agree with your point about competition....
...It will be interesting to see how he reacts to Third Point....
...Michael Sklar, develops “nonstandard trial designs”, which seems to basically use maths to speed up the process of developing pharmaceutical studies....
...(BBG) Big Pharma lobbies again While big US tech groups have said they support plans for a new, sweeping global tax deal, big pharmaceutical companies are quietly pushing back against it....
...It comes as rivals Apple, Amazon and Microsoft are also pushing into the potentially lucrative space, building healthcare services for consumers, physicians and pharmaceutical companies....
...They want to curb not only Big Tech, but a number of other industries with dominant players — finance and pharmaceuticals — with more regulation....
...There’s not really at this point a universal platform,” Siegel says. Another issue has been a tendency to over promise and under deliver....
...Its share price has risen 60 per cent since Third Point’s campaign was revealed in April 2019....
...Some believe that was the point. For Mr Cernich, the Caldera co-founder who is also being sued by Athene, the case was never really about confidential information....
...Aware of this tension, leaders of the project feel the need to point out that Manchester has not become “GSK city”....
...So far in 2018, 156 companies have raised nearly $43bn, the highest number and the largest amount at this point in the year since 2014, according to Dealogic....
...Bribery and corruption is another point of engagement with drug companies, says Ms Schaik....
...Dan Loeb, Third Point’s founder, has urged Nestlé to offload the stake, which it has held for more than four decades....
...Corporate earnings reports out today include Tencent, Alibaba Health, Man Wah Holdings, AusNet and CSPC Pharmaceutical....
...A year earlier, Ariad Pharmaceuticals was sold to the Japanese drugmaker Takeda for nearly $5bn, a 75 per cent premium....
...Gritstone scientists have analysed each one at a molecular level to provide thousands of different data points that can be fed through the sensitive computer programmes, including over one million protein...
...On transactions valued at between $1 and $5bn, Qatalyst’s average fee rate was 1.26 per cent, more than 50 basis points above the median rate....
...IG is calling European bourses to open as follows: The FTSE is set to open 20 points lower at 6848The CAC is set to open 11 points lower at 4410The DAX is set to open 8 points lower at 10585 Here are today...
...Daniel Loeb’s Third Point, by contrast, has generated 7.2 per cent this year through the end of September, on $16bn of assets....
...Mr Loeb, the chief executive of Third Point, recounted a litany of woes for hedge funds but also said recent market volatility should provide “excellent opportunities” for some active managers....
...Gambling odds point to the UK remaining, but opinion polls suggest the decision is finely balanced. It’s the biggest issue most Britons will ever vote on....
...Dan Loeb’s Third Point added 1.7m shares in the same period....
International Edition